bpc-157 human clinical trials randomized controlled trial Regeneration or Risk? A Narrative Review of for Musculoskeletal Healing Therapeutic potential of pro-angiogenic BPC157

Eussen SJ, de Groot LC, Clarke R, Schneede J, Ueland PM, Hoefnagels WH, et al: Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial

This translates to approximately 1.6 to 4 mcg per kilogram of body weight, extrapolated from effective rat doses using standard interspecies scaling factors

It is commonly recommended for babies, children, and individuals at higher risk of exposure or travel-related infection

Furthermore, we consider precautionary B12 treatment to be an appropriate and advisable response to such symptoms, due to the number of positive experience reports as well as the fact that blood measurements and other test factors are often misleading in this area

Book a consultation to discuss your health goals and get started with a personalized care plan